Neuzumab 440mg Injection 20ml
20ml Injection in VialMRP ₹19800.00
₹14850.00
25% OFF
Made by
LUPIN
Dosage
INJECTION
Expiry
Product Summary
| Salt Content | Trastuzumab(440.0 Mg) |
| Uses | Breast cancers |
| Therapy | Anti-neoplastic |
| Side effects | Chills, fever, flu-like symptoms, nausea, vomiting, increased muscle tension |
Assurance
available
Regulated
Medical Description
Neuzumab injection is an anti-cancer medication used by cancer specialists to treat specific types of breast cancer. It targets a protein called HER2, which is overexpressed in certain breast cancers. By binding to HER2, Neuzumab injection inhibits the growth of these cancer cells. Neuzumab injection is used in various treatment settings, including early-stage breast cancer with high HER2 levels and metastatic breast cancer. It may be administered alone or in combination with other cancer treatments like chemotherapy or hormone therapy, depending on the specific type and stage of the cancer.
Uses
Contraindications
- If you are allergic to trastuzumab or any of the other ingredients of Neuzumab injection.
- If you have severe breathing problems at rest due to your cancer or if you need oxygen treatment.
Side effects
- Chills
- Fever
- Flu-like symptoms
- Nausea
- Vomiting
- Increased muscle tension
- Shaking
- Headache
- Dizziness
- Breathing difficulties
- High or low blood pressure
- Heart rhythm disturbances (palpitations, heart fluttering, irregular heartbeat)
- Swelling of the face and lips
- Rash
- Fatigue (feeling tired)
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have ever had or might now have a hepatitis infection.
- You have a history of cardiac conditions, such as heart failure, coronary artery disease, or arrhythmias.
- You have previously received anthracycline-based chemotherapy.
- You experience symptoms of cardiac dysfunction, including shortness of breath, fatigue, or swelling.
- You have poorly controlled hypertension or other cardiovascular risk factors.
- You have a history of myocardial infarction, angina requiring treatment, or clinically significant valvular disease.
- You suffer from asthma or other respiratory conditions.
- You develop symptoms during or after infusion, such as shortness of breath, wheezing, hypotension, hypertension, urticaria, or chest pain.
- You experience delayed infusion-related symptoms hours or days after treatment.
- You have dyspnea (difficulty breathing) at rest due to advanced malignancy or other comorbidities.
- You experience any new or worsening respiratory symptoms, such as cough, chest tightness, or difficulty breathing.
- You have been treated with Neuzumab injection before and are considering re-treatment.
- You are pregnant, planning a pregnancy, or breastfeeding.
- You experience severe side effects, including persistent nausea, fatigue, or signs of infection.
- You notice worsening symptoms or develop new symptoms during treatment.
- You are taking other medications, especially those known to affect the heart or lungs, such as taxanes, gemcitabine, or radiation therapy.
Directions for Use
Storage and disposal
- Store in a refrigerator (2 °C – 8 °C). Keep the container in the outer carton to protect it from light.
- Keep it out of the reach of children
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:NEUZUMAB
Manufacturer Name:LUPIN
Address:<p>1. Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India</p>
Country of Origin:India
Vendor Details
Fulfillment Information: Neuzumab 440 MG Injection (20) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- Herceptin 150mg Powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 6 January 2025]
- Herceptin 150mg Powder for concentrate for solution for infusion - Patient Information Leaflet (PIL) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 6 January 2025]
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
